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Abstract
Background: Evidence suggests that coronary heart disease (CHD) is associated with increased anxiety and a high
incidence of comorbid anxiety and depression. However, the association between percutaneous coronary intervention
(PCI) and comorbid anxiety and depression has not been previously investigated. This study aims to determine the
relationship between PCI and anxiety and depression symptoms in CHD patients in terms of the occurrence, prone
factors, and long-term outcomes of CHD.
Methods: One hundred seventy CHD patients who underwent PCI treatment between September 2013 and February
2014 at the Second Hospital of Hebei Medical University were randomly selected. All patients independently completed
the Hospital Anxiety and Depression Scale (HADS) and a preoperative questionnaire; they also provided details regarding
their PCI-related concerns one day before PCI, as well as one day and one, three, six, and 12 months after PCI.
Results: PCI treatment was significantly associated with the symptoms of anxiety, depression, affective disorders, and
comorbid anxiety and depression (χ2 = 90.18, 54.45, 101.59, 64.83; p< 0.01) at each follow-up time point. Moreover, PCI
treatment was linearly correlated with each of these psychological issues (p < 0.01).
Conclusion: The prevalence of anxiety, depression, and comorbid anxiety and depression symptoms significantly
increases one day before and after PCI treatment; however, the incidence of these psychological issues significantly
decreases with time following PCI. A low level of education, apprehension with regard to nursing quality, potential
cardiac dysfunction, surgery sequelae, and surgery failure are also associated with a high prevalence of anxiety and
depression symptoms.
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Background
Anxiety and depression symptoms are commonly associ-
ated with coronary heart disease (CHD). A recent sys-
tematic review indicated that the overall prevalence of
depression in patients with CHD in China was 51 % [1],
among which 3.1–11.2 % of individuals suffered from se-
vere depression [1]. Previous studies have suggested that
depression is a risk factor for poor prognosis of CHD
[2–4]. Other evidence has also indicated that depression
increases the risk of myocardial infarction in CHD pa-
tients [5, 6]. CHD patients with depression are particularly
vulnerable to myocardial reperfusion injury when they
face psychological challenges, thus increasing the recur-
rence of acute coronary syndrome and mortality [5, 6].
Another psychological factor negativly associated with car-
diovascular disease is anxiety, which may occur alone or
in combination with depression. Watkins demonstrated
that the simultaneous occurrence of anxiety and depres-
sion had a significant adverse impact on the prognosis of
* Correspondence: cuiwei@medmail.com.cn
Department of Cardiology, The Second Hospital of Hebei Medical University,
No. 215, He Ping Xi Road, Shijiazhuang 05000, China
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gu et al. BMC Psychiatry  (2016) 16:259 
DOI 10.1186/s12888-016-0972-9
CHD [2]. Thus, the importance of focusing on comorbid
anxiety and depression in CHD patients has been empha-
sized [3]. Importantly, these findings indicate that anxiety
and depression are both risk factors for CHD and play im-
portant roles in the initiation, development, rehabilitation,
and prognosis of CHD.
Currently, percutaneous coronary intervention (PCI) is
considered one of the primary approaches for CHD treat-
ment. PCI significantly alleviates the symptoms of CHD,
reduces mortality, and substantially improves quality of
life [7]. The number of patients who receive PCI treat-
ment has increased annually. However, some patients may
develop psychological issues after PCI treatment because
of several factors [8–10], including a lack of 1) knowledge
regarding the disease and surgical intervention; 2) suffi-
cient medical education; or 3) correct information on
the surgical procedure. These psychological issues may
significantly affect a patient’s daily life and work activ-
ities. Previous studies have demonstrated that in gen-
eral, patients who underwent PCI surgery developed
affective disorders, including anxiety and depression
[11, 12]. However, the associations between PCI and
anxiety and depression symptoms in CHD patients in
terms of occurrence, risk factors, and the long-term
outcomes of CHD remain unknown. To the best of our
knowledge, this is the first study that aims to investi-
gate the incidence of anxiety and depression symptoms,




One hundred seventy hospitalized CHD patients (120
males and 50 females, aged 33–80 years old), who under-
went PCI at the Department of Internal Cardiology in our
hospital between September 2013 and February 2014,
were enrolled in this study. This study was approved by
the Ethics Committee of the Second Hospital of Hebei
Medical University. All patients were enrolled after pro-
viding written informed consent.
The inclusion criteria were as follows: age ≥ 18 years;
PCI was required based on coronary angiography re-
sults, individuals voluntarily participated in the psycho-
logical evaluation.
Exclusion criteria included a history of at least one of
the following conditions: mental illness or history of
prophylactics for mental illness; valvular heart disease
and/or cardiomyopathy; cognitive impairment; stroke;
or nervous system disorder due to liver, lung, kidney,
or other diseases. Individuals were also excluded be-
cause of a lack of ability to complete the psychological
evaluation due to severe illness, surgical emergency, or
lack of cooperation.
Methods
Assessment tools and methods
Hospital Anxiety and Depression Scale (HADS) consists
of 14 items, including 7 items that assess anxiety symp-
toms and 7 items that assess depression symptoms. The
scale was divided into two factors based on the CCMD-2
(Chinese Classification of Mental Disorders-2) diagnostic
criteria, and the Self-Rating Depression Scale (SDS) and
Self-Rating Anxiety Scale (SAS) were used as a reference
for comparative study. The threshold for anxiety or de-
pression was 8 points [13].
Preoperative and postoperative psychological question-
naires were administered.
(1) The preoperative questionnaire assessed the
following variables: 1) attitude towards CHD;
2) attitude towards PCI treatment of CHD; 3)
preoperative mood; 4) views regarding prospects
for stent treatment; 5) requirements regarding
surgeon; and 6) most significant concern prior
to surgery.
(2) The postoperative questionnaire assessed the
following items: 1) knowledge of the surgeon who
conducted the operation; 2) degree of satisfaction
regarding the stent therapy; 3) mood after PCI
treatment; 4) reconsideration of PCI; 5) physical
symptoms after PCI; and 6) the most significant
concern after surgery.
A three-stage system was applied to evaluate the first
five questions in the questionnaire. For example, the
requirement for the surgeon was divided into three
levels, including not strict, general, and very strict, rep-
resented by scores of 1, 2, and 3 points, respectively.
The sixth question consisted of 12 and 11 selectable
items, such as a fear of impaired heart function, sequela
after surgery, failure to receive attentive care, surgery
failure, and recurrence of CHD. Responses were divided
into two levels, concern and no-concern.
Main testing indicators and measurement methods
(1) The indicators related to anxiety and depression
symptoms include anxiety and depression scores on
the HADS, preoperative questionnaire,
preoperative concerns, understanding of the disease
prior to surgery, knowledge of the surgeon,
understanding of the surgery, postoperative
questionnaire, and postoperative concerns.
(2) Surgery-related issues include the diagnosis of
angina or myocardial infarction, diseased left main
artery, number of diseased blood vessels, blood
vessel where stent was placed, whether blood
vessel was completely processed, amount of
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heparin used in operation, and amount of contrast
agent used in operation.
(3) Disease history refers to the disease duration and a
history of hypertension, diabetes, hyperlipidemia,
or cerebral vascular disease.
(4) The general demographic information includes age,
sex, work location, education, marriage, and children.
The education levels were divided into five categories,
including illiteracy, elementary or junior high school,
high school or secondary vocational school,
university or junior college, and graduate and above.
(5) Supplementary examination indicators include
blood test results, high-sensitivity C-reactive
protein level, and liver and kidney function.
(6) Assessment of major adverse cardiovascular events
(MACE). The follow-up endpoint comprised the
occurrence of MACE within a 12-month follow-up
period, which included non-fatal myocardial
infarction, target lesion revascularization (TLR),
and all-cause death. Acute myocardial infarction
refers to an acute ST-segment elevation and an
acute non-elevation myocardial infarction. TLR
refers to the presence of vascular disease within
5 mm at bilateral ends of the stent, which requires
renewed PCI or coronary artery bypass graft
surgery. The mode of death includes cardiac and
non-cardiac death.
Procedures
All procedures were supervised by trained cardiologists,
who tested each patient one day before and after surgery.
All patients were allowed to independently complete the
questionnaires within 30 min. Patients who had difficulties
reading and/or understanding the questions presented in
the questionnaires were provided with limited counseling
to complete the assessments. Follow-up assessments were
performed either in the outpatient department or via tele-
phone at 1, 3, 6, and 12 months after surgery, at which
point anxiety and depression were assessed. To assess anx-
iety symptoms, the scores were divided into two categor-
ies: the anxious symptoms group (HADS-A ≥ 8 points)
and the non-anxious symptoms group (HADS-A < 8
points). To assess depression, the scores were divided into
two categories: the depressive symptoms group (HADS-
D ≥ 8 points) and the non-depressive symptoms group
(HADS-D < 8 points). The levels of anxiety and depression
symptoms and the presence of MACE were evaluated.
Statistical analysis
(1) SPSS version 13.0 (SPSS, Chicago, IL, USA) was
used for statistical analysis.
(2) Data are presented as the mean ± standard
deviation (SD) for measurement data; the count
data are expressed as percentages. Each set of data
was tested regarding normality and homogeneity
of variance. If data were normally distributed,
independent sample t-tests were used for
comparisons between two data sets. Otherwise, a
non-parametric test was used for data analysis.
The population rate or the constituent ratio of the
count data were analyzed using Chi-square tests.
(3) The prevalence of anxiety and depression
symptoms at different time points was compared
using Chi-square tests. A linear trend test and
post-multiple comparison were used to analyze the
relationship between the prevalence of anxiety and
depression symptoms and PCI at each time point.
(4) A multivariate logistic regression analysis was used
to analyze factors related to disease prevalence.
Demographic characteristics (such as gender and
age) and clinical characteristics (such as type of
disease, family history, high blood pressure, and
diabetes) were adjusted in the multivariate analysis




Of the 170 patients, 59 (34.70 %) patients, with a mean
age of 58 years (range: 50–64 years), had symptoms of
anxiety on the day before surgery, and 68.49 % of these
cases were male. Forty (23.50 %) patients with a mean
age of 58.50 years (range: 50.25–64.75 years) had symp-
toms of depression (60.00 % male; Table 1).
On the day before surgery, 74 (43.50 %) patients with a
mean age of 58 years (range: 50.00–64.00) had symptoms
of either anxiety or depression (67.57 % male). Further-
more, 25 (14.70 %) patients with a mean age 58 years
(range: 50.00–64.00 years) had symptoms of comorbid
anxiety and depression (60.00 % male; Table 2).
Determination of factors impacting anxiety and
depression symptoms at different time points
The symptoms of anxiety, depression, affective disor-
ders, and comorbid anxiety and depression comprised
dependent variables. A univariate analysis of risk factors
was conducted with age, sex, family history of depres-
sion or anxiety as the independent variables. A multivari-
ate logistic regression analysis was performed. Following
adjustment for demographic and clinical characteristics,
as well as other confounding factors, a high level of educa-
tion was identified as a protective factor against preopera-
tive symptoms of anxiety, depression, affective disorders,
and comorbid anxiety and depression. Odds ratios (ORs)
were 0.56 (95 % confidence interval [CI], 0.34–0.91), 0.34
(95 % CI, 0.19–0.66), 0.44 (95 % CI, 0.26–0.73), and 0.430
(95 % CI, 0.21–0.88), respectively. The fear of surgery
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sequelae was a risk factor for preoperative symptoms of
anxiety with an OR of 2.46 (95 % CI, 0.34–0.91). Concerns
regarding the quality of nursing and potential cardiac func-
tion impairment were risk factors for preoperative symp-
toms of depression with ORs of 4.03 (95 % CI, 1.14–12.33)
and 3.11 (95 % CI, 1.37–7.06), respectively. Fear of nursing
quality and cardiac function impairment were risk factors
for affective disorders symptoms of with ORs of 3.61 (95 %
CI, 1.20-10.87) and 2.09 (95 % CI, 1.02-4.27), respectively.
Furthermore, fear of heart function impairment was a risk
factor for symptoms of comorbid anxiety and depression
with an OR of 3.72 (95 % CI, 1.52-9.13; Table 3).
Concern over cardiac function damage was a risk factor
for postoperative symptoms of anxiety and comorbid anx-
iety and depression with ORs of 2.67 (95 % CI, 1.12-6.41)
and 2.38 (95 % CI, 1.05-5.41), respectively (Table 3).
Next, the symptoms of anxiety, depression, affective
disorders, and comorbid anxiety and depression were
considered dependent variables, and smoking, drinking,
amount of physical activity, regular medication, and fam-
ily history of affective disorders during 12-month follow-
up were considered independent variables. During the
12 months after surgery, presence of symptoms was a
risk factor for anxiety, depression, affective disorders,
and comorbid anxiety and depression, with ORs of 3.14
(95 % CI, 1.31–7.51), 3.03 (95 % CI, 1.32–6.96), 2.79
(95 % CI, 1.27–6.14), and 4.74 (95 % CI, 1.81–12.38), re-
spectively. Unexpectedly, a history of drinking was a
protective factor against depression symptoms, with an
OR of 0.254 (95 % CI, 0.07–0.89; Table 3).
Changes in the prevalence of anxiety and depression
over time
The prevalence of anxiety symptoms at each follow-up
time point was significantly different (χ2 = 90.18; p < 0.01),
and it linearly correlated with the time trend (p < 0.01).
Table 1 Prevalence of anxiety and depression based on demographic and clinical indicators one day before PCI
Parameters Group Group
n (%) Anxiety Non-anxiety P Depression Non-depression P
(n = 59) (n = 111) (n = 40) (n = 130)
Female 18 (36.00) 32 (64.00) 0.819 16 (32.00) 34 (68.00) 0.093
Alone 3 (21.40) 11 (78.60) 0.384 7 (50.00) 7 (50.00) 0.023
Occupation
Farmers 35 (38.00) 57 (62.00) 0.591 29 (31.50) 63 (68.50) 0.014
Workers 11 (32.40) 23 (67.60) 7 (20.60) 27 (79.40)
Services 13 (29.50) 31 (70.50) 4 (9.10) 40 (90.90)
Reimbursement
Expense 5 (45.50) 6 (54.50) 0.043* 2 (18.20) 9 (81.80) 0.014
Provincial health insurance 8 (20.50) 31 (79.50) 6 (15.40) 33 (84.60)
NCMS 39 (42.90) 52 (57.10) 30 (33.00) 61 (67.00)
Medicare places 7 (24.10) 22 (75.90) 2 (6.90) 27 (93.10)
Monthly income
<1000 yuan 27 (39.10) 42 (60.90) 0.373 26 (37.70) 43 (62.30) 0.001
1000–3000 yuan 27 (30.00) 63 (70.00) 11 (12.20) 79 (87.80)
3000–5000 yuan 5 (50.00) 5 (50.00) 3 (30.00) 7 (70.00)
>5000 yuan 0 (0.00) 1 (100.00) 0 (0.00) 1 (100.00)
Work location
City 9 (23.10) 30 (76.90) 0.142 4 (10.30) 35 (89.70) 0.039
County 14 (32.60) 29 (67.40) 9 (20.90) 34 (79.10)
Rural 36 (40.90) 52 (59.10) 27 (30.70) 61 (69.30)
Education
Illiteracy 9 (75.00) 3 (25.00) 0.042 8 (66.70) 4 (33.30) 0.004
Primary or junior high school 32 (33.00) 65 (67.00) 24 (24.70) 73 (75.30)
High school or secondary vocational school 15 (30.60) 34 (69.40) 7 (14.30) 42 (85.70)
Bachelor’s degree or junior college 3 (27.30) 8 (72.70) 1 (9.10) 10 (90.90)
Master’s degree or above 0 (0.00) 1 (100.00) 0 (0.00) 1 (100.00)
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One day before surgery, the occurrence rate of anxiety
symptoms was 34.70 % (59/170), which significantly in-
creased one day after surgery (54.70 %, χ2 = 13.75; p <
0.001). There was no significant difference in the preva-
lence of anxiety symptoms between one day and 1 month
after surgery (χ2 = 1.18; p = 0.278); however, the prevalence
was significantly decreased three months after the oper-
ation (χ2 = 31.29; p < 0.001). There was no significant dif-
ference in the prevalence of anxiety symptoms between
the 3rd and 6th or 12th months (χ2 = 2.17, p = 0.141 and
χ2 = 0.49, p = 0.485, respectively; Fig. 1, Table 4).
Similar to the findings related to anxiety symptoms, a
significant difference (χ2 = 54.45; p < 0.01) in the preva-
lence of depression symptoms after PCI was identified at
each time point, which linearly correlated with the time
change trend (p < 0.01). One day before surgery, the
prevalence of depression symptoms was 23.50 % (40/170),
and it was significantly increased one day after surgery
(χ2 = 16.96; p < 0.001). There was no significant differ-
ence in the occurrence rate of depression symptoms be-
tween the 1st day postoperation and the 1st or 3rd months
(χ2 = 0.58, p = 0.447 and χ2 = 0.00, p = 1.000, respectively).
However, the prevalence of depression at the 6th month
time point was significantly decreased compared with the
3rd month (χ2 = 9.95; p < 0.003); however, no significant
difference was identified compared with the 12th month
(χ2 = 1.90, p = 0.168; Fig. 1, Table 4).
There was a significant difference (χ2 = 101.59; p < 0.01)
in the prevalence of affective disorders symptoms after PCI
at each follow-up time point, which changed linearly with
time (p < 0.01). A total of 43.50 % (74/170) of the patients
exhibited an affective disorder one day before PCI. One day
after surgery, the percentage of patients who had symptoms
of an affective disorder was significantly increased (χ2 =
27.76; p < 0.001). There was no significant difference in the
occurrence of symptoms of mood disorders between the











Female 24 (48.00) 26 (52.00) 0.448 10 (20.00) 40 (80.00) 0.208
Alone 7 (50.00) 7 (50.00) 0.610 3 (21.40) 11 (78.60) 0.437
Occupation
Farmers 46 (50.00) 46 (50.00) 0.129 18 (19.60) 74 (80.40) 0.126
Workers 14 (41.20) 20 (58.80) 4 (11.80) 30 (88.20)
Services 14 (31.80) 30 (68.20) 3 (6.80) 41 (93.20)
Reimbursement
Expense 6 (54.50) 5 (45.50) 0.004 1 (9.10) 10 (90.90) 0.089
Provincial health insurance 10 (25.60) 29 (74.40) 4 (10.30) 35 (89.70)
NCMS 50 (54.90) 41 (45.10) 19 (20.90) 72 (79.10)
Medicare places 8 (27.60) 21 (72.40) 1 (3.40) 28 (96.60)
Monthly income
<1000 yuan 38 (55.10) 31 (44.90) 0.031 15 (21.70) 54 (78.30) 0.025
1000–3000 yuan 31 (34.40) 59 (65.60) 7 (7.80) 83 (92.20)
3000–5000 yuan 5 (50.00) 5 (50.00) 3 (30.00) 7 (70.00)
>5000 yuan 0 (0.00) 1 (100.00) 0 (0.00) 1 (100.00)
Work location
City 9 (23.10) 30 (76.90) 0.009 4 (10.30) 35 (89.70) 0.211
County 19 (44.20) 24 (55.80) 4 (9.30) 39 (90.70)
Rural 46 (52.30) 42 (47.70) 17 (19.30) 71 (80.70)
Education
Illiteracy 10 (83.30) 2 (16.70) 0.010 7 (58.30) 5 (41.70) 0.003
Primary or junior high school 45 (46.40) 52 (53.60) 11 (11.30) 86 (88.70)
High school or secondary vocational school 16 (32.70) 33 (67.30) 6 (12.20) 43 (87.80)
Bachelor’s degree or junior college 3 (27.30) 8 (72.70) 1 (9.10) 10 (90.90)
Master’s degree or above 0 (0.00) 1 (100.00) 0 (0.00) 1 (100.00)
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1st and 3rd month time points (χ2 = 0.06, p = 0.811 and
χ2 = 6.84, p = 0.009, respectively); however, the prevalence
was significantly lower at the 6th month (χ2 = 14.24; p <
0.001) and further decreased at the 12th month follow-up
time point (χ2 = 20.88, p < 0.001; Fig. 1, Table 5).
The prevalence of comorbid anxiety and depression
symptoms was significantly different and linearly corre-
lated with time (χ2 = 64.83; p < 0.01). One day after sur-
gery, the number of patients with comorbid anxiety and
depression symptoms was significantly increased com-
pared with one day before surgery (χ2 = 8.53; p <
0.0033); however, there was no significant difference
between one day and 1 month after surgery (χ2 = 0.02;
p = 0.903), and the comorbidity rate was significantly
lower at the 3rd month compared with the 1st month
(χ2 = 25.82; p < 0.001). After 3 months, there were no
significant changes during the 12-month follow-up
period in comorbid symptoms (χ2 = 0.50, p = 0.479 and
χ2 = 3.45, p = 0.063 for 3 and 12 months, respectively;
Fig. 1, Table 5).
MACE
No MACE were identified during the 12-month follow-
up period.
Fig. 1 Change trend in prevalence of anxiety and/or depression during different periods of percutaneous coronary intervention
Table 3 Binary logistic regression analysis for factors related to the prevalence of anxiety and/or depression in different periods of
PCI
Symptom classification Parameters OR 95 % CI p value
1 day before operation Anxiety High education level 0.56 0.34–0.91 0.02*
Surgical complications 2.46 1.23–4.94 0.011*
Depression High education level 0.34 0.18–0.66 0.001**
Inattentive Care 4.03 1.14–12.33 0.014*
Cardiac dysfunction 3.11 1.37–7.06 0.007**
Affective disorder High education level 0.44 0.27–0.73 0.001**
Inattentive Care 3.61 1.20–10.87 0.023*
Surgical complications 2.09 1.03–4.27 0.044*
Cormorbid anxiety and depression High education level 0.43 0.21–0.88 0.02*
Cardiac dysfunction 3.72 1.52–9.13 0.004**
1 day after operation Anxiety Cardiac dysfunction 2.67 1.12–6.41 0.028*
Comorbid anxiety and depression Cardiac dysfunction 2.38 1.05–5.41 0.038*
12 months after operation Anxiety Symptoms present 3.14 1.31–7.51 0.01*
Depression Symptoms present 3.02 1.32–6.96 0.009**
History of drinking 0.25 0.07–0.89 0.032*
Affective disorder Symptoms present 2.79 1.27–6.14 0.011*
Comorbid anxiety and depression Symptoms present 4.74 1.81–12.38 0.002**
*P < 0.05; **P < 0.01; OR odds ratio, CI confidence interval
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Discussion
In the present study, we investigated the prevalence of
anxiety symptoms, depression symptoms, and comorbid
anxiety and depression symptoms in CHD patients after
PCI. Our findings indicated that the prevalence of these
symptoms significantly increased one day before and
after PCI treatment; however, these rates significantly
decreased over time after PCI. In addition, a high level
of education protected patients from developing pre-
operative symptoms of anxiety, depression, and comor-
bid anxiety and depression. Patients who exhibited
apprehension with regard to nursing quality, potential
cardiac dysfunction, surgery sequelae, and surgery failure
also exhibited a high prevalence of anxiety and depres-
sion symptoms.
Prior to PCI, the prevalence rates of anxiety symptoms,
depression symptoms, affective disorders symptoms, and
comorbid anxiety and depression symptoms were substan-
tially increased compared with the general population.
Previous studies [2, 3, 14] have also demonstrated that
CHD patients had increased anxiety symptoms and a high
incidence of comorbid anxiety and depression symptoms.
Simmonds reported that the prevalence of depression
symptoms in elderly patients with CHD was 60.7 % and
was associated with family function [15]. Frasurc-Smith
studied 785 hospitalized patients with acute myocardial in-
farction and determined that 69 % of the patients devel-
oped various types of anxiety symptoms [14]. Our study
indicated that the reason why patients exhibited increased
levels of anxiety and depression before PCI may be
attributed, at least in part, to the patients’ concerns re-
garding nursing quality, potential heart function dam-
age, surgical sequelae, and surgery failure. Furthermore,
other reasons that accounted for the increased preva-
lence of psychological issues in CHD patients after PCI
may include anxiety induced by the frequent onset of
CHD symptoms and the operation itself.
Our study also identified a significantly increased preva-
lence of anxiety symptoms, depression symptoms, and co-
morbid anxiety and depression symptoms after PCI. The
patients with comorbid anxiety and depression obtained a
lower score on the postoperative questionnaire following
surgery, which suggested that these patients had limited
understanding of the disease and surgery, exhibited lower
satisfaction with the surgery, and felt physically unwell fol-
lowing surgery. In addition, a fear of the risks associated
with PCI treatment and the potential complications, such
as in-stent restenosis and stent thrombosis, were likely to
potentiate mental stress, which may contribute to the post-
operative incidence rates of anxiety and depression symp-
toms. The exact mechanisms that underlie the increased
occurrence rate of comorbid anxiety and depression symp-
toms after PCI are not clear. However, some studies
suggest that chronic anxiety is typically accompanied by a
series of pathophysiological processes, including increased
sympathetic nervous system activity [13] and inflammation
[16–19]. Moreover, anxiety or depression symptoms has
been demonstrated to increase the inflammatory response
in CHD patients [20]. Additionally, the surgery itself may
increase sympathetic activity and inflammatory reactions.
Table 4 Changes in the trends of anxiety and/or depression prevalence at different PCI time points
Time Depression (%) p Afterwards, multiple comparisons Anxiety (%) p Afterwards, multiple comparisons


















1 day after surgery (T0) 76 (44.70) 93 (54.70)
1 month (T1) 83 (48.80) 83 (48.80)
3 months (T3) 76 (44.70) 34 (20.20)
6 months (T6) 48 (28.20) 46 (26.70)
12 months (T12) 37 (21.80) 29 (17.10)
**P < 0.01;***P < 0.003
Table 5 Change trend of anxiety and/or depression prevalence during different periods of PCI
Time Depression P Afterwards multiple
comparisons
Anxiety P Afterwards multiple
comparisonsn (%) n (%)


















1 day after surgery (T0) 122 (71.80) 47 (27.60)
1 month (T1) 120 (70.60) 46 (27.10)
3 months (T3) 99 (58.20) 11 (6.50)
6 months (T6) 86 (50.60) 8 (4.70)
12 months (T12) 45 (26.50) 21 (12.40)
**P < 0.01; ***P < 0.003
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Our current findings also demonstrated that changes in
anxiety and depression symptoms over time after PCI ex-
hibited a linear correlation with time. Following PCI, the
prevalence of postoperative anxiety, comorbid anxiety,
and depression symptoms increased for approximately
one month, whereas the prevalence of depression and
mood disorder symptoms persistently increased for ap-
proximately three months. These results are in contrast
with a previous report [21], in which acute myocardial in-
farction (AMI) patients were followed for 18 months and
exhibited increased anxiety, but not depression, at the
early stage of AMI. After 3–18 months, the levels of anx-
iety and depression were similar to the control population.
The discrepancies between the previous and current stud-
ies may have resulted from the differences in the patient
characteristics and the durations of follow-up study. In
the present study, the changes in the prevalence of anxiety
and depression symptoms were most likely due to the fol-
lowing reasons: I) the blood flow to the ischemic areas
was gradually restored following PCI, which subsequently
reduced the occurrence of anxious and depressive symp-
toms caused by ischemia; II) potential complications, such
as heart function damage, which lead to concerns, did not
occur with time after PCI: thus, the patients’ anxiety and
depression symptoms may have been alleviated; and III)
following the improvement in symptoms, the patients
gradually resumed normal daily activities and aerobic
exercise, which has been demonstrated to alleviate the
symptoms of depression in CHD patients similar to the
outcomes of psychotherapy and antidepressant treatment
[22]. Exercise therapy is also currently considered a core
component of cardiac rehabilitation [23], which has been
proven to effectively reduce the incidence of depression
symptoms and cardiac events, improve patients quality of
life, and subsequently diminish the risk of CHD morbidity
and mortality [22, 24, 25].
A high level of education was also demonstrated to
protect patients from developing preoperative symptoms
of anxiety, depression, and comorbid anxiety and depres-
sion. This protection was most likely attributed to the
fact that the patients with a lower educational level had
limited knowledge regarding their illness and exhibited
increased concern regarding the adverse consequences
of the disease. Furthermore, concern over potential car-
diac function damage on day 1 following the operation
was a risk factor for postoperative symptoms of anxiety
alone, as well as comorbid anxiety and depression. Taken
together, patients with a low education level or fear of
nursing quality, potential cardiac dysfunction, surgery
sequelae, or surgery failure exhibited an increased preva-
lence of anxiety and depression symptoms.
In the present study, the patients did not exhibit
MACEs during the 12-month follow-up, which may be
because the patients enrolled in this study were scheduled
for PCI treatment, and the surgery was well prepared
ahead of time. However, we could not rule out the possi-
bility that the lack of MACE may be associated with the
small sample size and short follow-up period. The current
finding is different from several previous studies demon-
strating that depression increased short-term mortality in
CHD patients [23, 26–28]. Several studies have also indi-
cated that the long-term prognosis of CHD patients was
significantly correlated with depression [29–31]. However,
not all studies have identified a link between anxiety and
adverse clinical outcomes in CHD patients; for example,
no apparent correlation was identified between anxiety
and the mortality rate of hospitalized patients with AMI
[32–34]. Therefore, additional investigations with a larger
sample size and longer follow-up time period are required
to clarify the impact of anxiety and depression symptoms
on the prognosis of patients after PCI.
However, there are several study limitations that must
be considered in the interpretation of our findings. First,
the HADS is widely used by physicians in general hospi-
tals to assess suspected anxiety or depression disorders in
patients. However, the HADS is not a standardized criter-
ion for the diagnosis of anxiety or depression, which may
result in false positive results. Second, many demographic
and clinical characteristics of the patients were included.
Nevertheless, the sample size is relatively small, which
may lead to bias regarding our results. In our future study,
the relationship between PCI and anxiety and depression
symptoms in CHD patients will be investigated by includ-
ing a large sample of subjects. Third, follow-up assess-
ments were performed in the outpatient department or
via telephone. Most patients were followed up with in the
outpatient department. However, a few patients were
followed up with by telephone, for various reasons. Thus,
we could not rule out that the follow-up interview
through telephone may influence the results.
Conclusions
Our current findings demonstrated that the symptoms
of anxiety and depression change over time after PCI in
CHD patients. Our results provide a framework for
monitoring the symptoms of anxiety and depression via
a non-pharmacologic intervention and a foundation for
further investigations regarding the association between
anxiety, depression and long-term prognosis after PCI.
These findings are also conducive to achieving health
objectives for PCI patients.
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